01 33JANSSEN PRODS
01 17390791
02 97700645
03 88148374
04 28754065
05 29296769
06 210039718
07 110786518
08 87700645*PED
01 22Y
02 11Blank
01 24Y
02 9Blank
01 12025-04-17
02 92026-12-26
03 82027-06-26
04 82029-09-03
05 42032-08-15
06 22032-10-06
07 12038-07-19
Patent Expiration Date : 2032-08-15
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8754065
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210455
Patent Use Code : U-2352
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2029-09-03
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205395
Patent Use Code : U-1279
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2032-08-15
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210455
Patent Use Code : U-2352
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2029-09-03
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210455
Patent Use Code : U-2353
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210455
Patent Use Code : U-2767
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210455
Patent Use Code : U-2768
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210455
Patent Use Code : U-2766
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2029-09-03
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205395
Patent Use Code : U-2939
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2038-07-19
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 10786518
Drug Substance Claim :
Drug Product Claim :
Application Number : 210455
Patent Use Code : U-2978
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-07-19
Patent Expiration Date : 2032-08-15
COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 8754065
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210455
Patent Use Code : U-2765
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-15
